Inhibition of β-amyloid formation as a therapeutic strategy

Expert Opinion on Therapeutic Patents

Volumn 9, Issue 2, 1999, Pages 135-146

  Moore, C L ^a   Wolfe, M S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Alzheimer's disease; Neurotoxicity; Proteases; Treatment

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; BETA SECRETASE; CATHEPSIN D; ENZYME INHIBITOR; PROTEINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY; ENZYME ACTIVATION; FIBER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 0032930444     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.9.2.135     Document Type: Review

References (84)